Surprisingly, we found that TrkC expression was markedly elevated in CRC tissues of patients relative to normal tissue samples, correlating with increased expression of NT-3, through analysis of TrkC and NT-3 expression using publicly available microarray, RNA-sequence and patient clinical data. The gene discussed is NTF3; the disease is colorectal carcinoma.